Dispensed: The untold story of Moderna — Building a new future for medicine — Startups poised to take off
Advertisement
Lydia Ramsey
May 29, 2020, 21:18 IST
Samantha Lee/Business Insider
Advertisement
Hello,
Welcome to Dispensed, Business Insider's weekly healthcare newsletter, in which we're feeling very grateful for last week's long weekend. I can definitely appreciate the benefits of a four-day workweek — at least amid a pandemic.
Merck's peer Gilead Sciences is leading the search for an effective treatment for COVID-19, the disease caused by the novel coronavirus.
Advertisement
This week, I took a look at the three-decade history of Gilead, the company behind one of the most promising treatments for COVID-19, remdesivir. The company has a long history in antivirals, dating back to the 90s. I have to say, I had a lot of fun looking through Gilead's 1992 S-1 from its initial public offering while reporting out the story.
We've spent some time in this newsletter talking about where the money from the CARES Act has gone to help medical practices financially hit hard by the pandemic.
Meanwhile, clinics and doctors who get paid by Medicaid to treat the poor are still waiting on their stimulus cash, two months after Trump signed the stimulus bill. Kimberly has the full story on the delay.
Top execs at the companies told me about how they transitioned largely in-person practices online, how they're faring financially, and what they're planning for during this pandemic period.
Healthcare startups that are poised to take off amid the pandemic
As we brace for the subsequent waves of the pandemic, we're getting a better sense of the role technology could play in making future responses more effective.
For instance, Google is teaming up with hospital chain HCA Healthcare and technology consulting firm SADA to track data on the novel coronavirus, Blake Dodge reports. Called the National Response Portal, it'll collect information such as how many hospital beds are in use, test results, and ventilator use. It won't collect personal information, Blake reports.
For better or for worse, the pandemic has also set up some health-tech startups for success.
Blake teamed up with our tech colleague Tyler Sonnemaker to ask 13 top venture capital investors which startups they think will thrive amid the pandemic. They identified 26 companies to keep an eye on.
What are you doing for fun while remaining social distant this summer? Send your plans/hobbies/news tips to me at lramsey@businessinsider.com, or you can reach the entire team at healthcare@businessinsider.com.
NewsletterSIMPLY PUT - where we join the dots to inform and inspire you. Sign up for a weekly brief collating many news items into one untangled thought delivered straight to your mailbox.